comparemela.com

Latest Breaking News On - Sarcoma medical oncology - Page 5 : comparemela.com

Agenus (AGEN) Q1 2023 Earnings Call Transcript

AGEN earnings call for the period ending March 31, 2023.

United statesSan franciscoComunidad autonoma de catalunaChristine klaskinEmily bodnarMayank mamtanib rileyYelena janjigianMatt phipps william blairGaro armenWilliam blairMayank mamtaniBruno bockornyBreelyn wilkyMike kingZach armanAnthony el khoueiry

AGENUS INC : Stock Market News and Information | AGEN| US00847G7051

AGENUS INC. : News, information and stories for AGENUS INC. | Nasdaq: AGEN | Nasdaq

United statesBreelyn wilkyClinical researchUniversity of colorado medicineAmerican society of clinical oncologyMary crowley cancer researchAmerican societyClinical oncologySarcoma medical oncologyDeputy associate directorColorado medicineOral abstract sessionAntibody designedAvoid hepatoxicityAdvanced solid tumorsMinal barve

Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers

Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers - read this article along with other careers information, tips and advice on BioSpace

United statesBreelyna wilkyNico frelickBreelyn wilkyCompany phaseSociety for immunotherapy of cancerSociety for immunotherapy of cancer takenAgenus incExchange commissionUniversity of colorado school medicineSteveno dayChief medical officerProgression free survivalOverall survivalPrincipal investigatorSarcoma medical oncology

Agenus (AGEN) Q3 2022 Earnings Call Transcript

AGEN earnings call for the period ending September 30, 2022.

United statesComunidad autonoma de catalunaLarry nortonDhan chandMayank mamtaniBree wilkyMatt phipps william blairGaro armenDavid daiNico frelickTodd yanceyMatt phippsChristine klaskinMayank mamtanib rileyBreelyn wilkyPatricia carlos

Agenus to Host The Road Taken R&D Event on November 12, 2022

Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections,

United statesJoseph grossmanEthan lovellBreelyn wilkyPatricia carlosMichael atkinsExchange commissionClinical research university of colorado medicineSociety lifestyleResearch development taken onAffairs communicationsPrudential towerRoad takenDeputy directorActing chiefOncology medstar georgetown university hospital

vimarsana © 2020. All Rights Reserved.